Advertisement
UK markets open in 3 hours 18 minutes
  • NIKKEI 225

    37,818.11
    -641.97 (-1.67%)
     
  • HANG SENG

    17,320.26
    +118.99 (+0.69%)
     
  • CRUDE OIL

    82.81
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,320.90
    -17.50 (-0.75%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,678.96
    -1,852.77 (-3.46%)
     
  • CMC Crypto 200

    1,388.67
    -35.43 (-2.49%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Why AnaptysBio Trounced the Market on Thursday

Why AnaptysBio Trounced the Market on Thursday

AnaptysBio (NASDAQ: ANAB) rose by just over 11% on Thursday, as a high-profile bank has become more optimistic on the stock, to put it lightly. J.P. Morgan analyst Anupam Rama upgraded his recommendation on AnaptysBio stock. Rama is basing his enthusiasm on the company's upcoming official data release for its phase 2 clinical trial of imsidolimab.